Indaptus Therapeutics, Inc.

NASDAQ:INDP

Biotechnology

Healthcare
$3.29 -2.21%

-$0.03 today

Market cap
$372.57M
Beta
1.14
P/E (TTM)
-0.2
EPS (TTM)
-$8.70
52W Low $0.92High $8.69

Volume 0.17M

Average 0.97M

INDP Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How INDP compares with its peers on the latest reported figures

No competitor Net Margin figures are available to compare.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development2.52M6.32M7.62M7.25M9.34M
Selling, General & Admin5.21M8.59M8.76M8.11M10.49M
Operating Expenses7.73M14.91M16.38M15.37M19.83M
Depreciation & Amortization1.4K1.78K1.28K7350
EBITDA(7.71M)(14.32M)(15.42M)(15.02M)(20.85M)
EBITDA Margin—————
Operating Income(7.73M)(14.91M)(16.38M)(15.37M)(19.83M)
Operating Margin—————
Interest Income17.72K588.11K000
Interest Expense00000
Other Income / Expenses17.72K588.11K955K343.72K(1.02M)
Income Before Tax(7.71M)(14.32M)(15.42M)(15.02M)(20.85M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(7.71M)(14.32M)(15.42M)(15.02M)(20.85M)
Net Margin—————
EPS (Basic)(1.89)(1.73)(1.84)(1.61)(21.58)
EPS (Diluted)(1.89)(1.73)(1.84)(1.61)(21.58)
Weighted Avg Shares4.09M8.26M8.4M9.36M966.12K
Weighted Avg Shares (Diluted)4.09M8.26M8.4M9.36M966.12K

Indaptus Therapeutics, Inc.

NASDAQ:INDP

Intrinsic Alpha fair value

Locked

Current Price

$3.29

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.